Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/5NRA stock hub

FRA/5NRA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/5NRAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.8B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/5NRAFRA/5NRA

—

Loading chart…

In the news

Latest news · FRA/5NRA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9,904.2

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/5NRA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

157

Groups with data

Currency

EUR

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	DE
Employees	103
Employees Change	-5%
Employees Change Percent	-4.63
Enterprise value	EUR 1.8B
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.8B
Price	EUR 34
Price currency	EUR
Rev Per Employee	325,930x
Sic	2836
Symbol	fra/5NRA
Website	https://www.nanobiotix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.34%
EV Earnings	-76.46x
EV/FCF	-53.95x
EV/Sales	56.21x
FCF yield	-1.9%
Forward P/E	9,904.16x
P/B ratio	-21.18x
P/S ratio	54.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-33.39%
EBITDA Margin	-32.18%
Gross margin	100%
Gross Profit	EUR 32.6M
Gross Profit Growth	220.83%
Gross Profit Growth3 Y	-8.25%
Gross Profit Growth5 Y	37.05%
Net Income	EUR -24M
Pretax Margin	-73.51%
Profit Margin	-73.52%
Profit Per Employee	EUR -239,610
ROA	-10.06
Roa5y	-28.61
ROCE	-106.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	1,012.95%
Cagr3y	73.57%
Cagr5y	24.43%
Revenue Growth3 Y	-8.25x
Revenue Growth5 Y	37.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.48
Assets	EUR 67.8M
Cash	EUR 52.8M
Current Assets	EUR 62.8M
Current Liabilities	EUR 57.5M
Debt	EUR 95.3M
Debt FCF	EUR -2.81
Equity	EUR -84.5M
Interest Coverage	-1.05
Liabilities	EUR 152.2M
Long Term Assets	EUR 5M
Long Term Liabilities	EUR 94.7M
Net Cash	EUR -42.6M
Net Cash By Market Cap	EUR -2.38
Tangible Book Value	EUR -84.5M
Tangible Book Value Per Share	EUR -1.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.09
Net Working Capital	EUR -43.2M
Quick ratio	1.05
Working Capital	EUR 5.2M
Working Capital Turnover	EUR 8.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.17%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	1,011.11%
200-day SMA	18.02
3Y total return	423.08%
50-day SMA	27.67
50-day SMA vs 200-day SMA	50over200
5Y total return	198.25%
All Time High	36.4
All Time High Change	-6.59%
All Time High Date	2026-05-07
All Time Low	2.44
All Time Low Change	1,293.44%
All Time Low Date	2024-12-06
ATR	1.71
Ch YTD	80.85
High	35.8
High52	36.4
High52 Date	2026-05-07
High52ch	-6.59%
Low	34
Low52	2.96
Low52 Date	2025-05-09
Low52ch	1,048.65%
Ma50ch	22.87%
Price vs 200-day SMA	88.67%
RSI	64.58
RSI Monthly	88.14
RSI Weekly	75.29
Sharpe ratio	2.91x
Sortino ratio	6.12
Total Return	-1.17%
Tr YTD	80.85
Tr1m	29.77%
Tr1w	25.93%
Tr3m	92.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -10.9M
Operating margin	-33.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,135,572%
Net Borrowing	38,189,000
Shares Insiders	3.28%
Shares Institutions	12.02%
Shares Qo Q	1.69%
Shares Yo Y	1.17%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -37.5M
Average Volume	1.05x
Bv Per Share	-1.75
CAPEX	EUR -538,000
Ch1m	29.77
Ch1w	25.93
Ch1y	1,011.1
Ch3m	92.09
Ch3y	423.1
Ch5y	198.2
Ch6m	100
Change	-6.59%
Change From Open	-5.03
Close	36.4
Days Gap	-1.65
Depreciation Amortization	393,000
Earnings Date	2026-05-22
EBIT	EUR -10.9M
EBITDA	EUR -10.5M
EPS	EUR -0.5
F Score	2
FCF	EUR -34M
FCF EV Yield	-1.85x
Financing CF	37,416,000
Fiscal Year End	December
Founded	2,003
Income Tax	EUR 3,000
Investing CF	-578,000
Is Primary Listing	0
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Ma150	21.58
Ma150ch	57.58%
Ma20	28.58
Ma20ch	18.96%
Net CF	3,014,000
Next Earnings Date	2026-05-22
Open	35.8
Position In Range	0
Ppne	4,170,000
Price Date	2026-05-08
Relative Volume	19.05x
Revenue	32,593,000x
SBC By Revenue	10.86x
Share Based Comp	3,539,000
Tax By Revenue	0.01x
Tr6m	100%
Z Score	1.11

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/5NRA pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/5NRA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/5NRA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.0%

Share of float held by funds and institutions

Insider ownership

+3.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.2%

Negative means the company is buying back shares.

Technical

FRA/5NRA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.6

Neutral momentum band

Price vs 200-day MA

+88.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.91

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/5NRA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/5NRA stock rating?

fra/5NRA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/5NRA analysis?

The full report lives at /stocks/fra/5NRA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/5NRA?

The latest report frames fra/5NRA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/5NRA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.